Fibroblast Growth Factor 23 (FGF23) (Human) ELISA Kit

Description

FGF23 is a biomarker for osteoporosis and cardiovascular calcification.

Citations:

Anne-Sophie Bargnoux et al. "Biomarkers of vascular calcifications: what are analytical limits to apply â€œresearch-gradeâ€ diagnostic kits into daily practice?" doi: 10.1684/abc.2015.1043.
Muhammed Kizilgu, et al. "Is fibroblast growth factor 23 a new cardiovascular risk marker in gestational diabetes?" Arch Endocrinol Metab. 2017 Dec;61(6):562-566. doi: 10.1590/2359-3997000000287
Takir M, Aysu F. Association Between Coronary Flow Reserve, Klotho and Fibroblast Growth Factor 23 in Patients with Acromegaly. EJMO 2019;3(1):14-21.
F. Bob, A. Schiller. et al. "Rapid Decline of Kidney Function in Diabetic Kidney Disease." Nefrologia 2019:39(3): 250-25 https://doi.org/10.1016/j.nefroe.2019.04.002
Flaviu Bob, Adalbert Schiller. et al.Rapid Decline of Kidney Function in Diabetic Kidney Disease is Associated with High Soluble Klotho Levels. Nefrologia 2019; 39(3): 250-257 https://doi.org/10.1016/j.nefroe.2019.04.002

Features

Size: 96 T
Standard Range: 31.25-2000 pg/ml
Sensitivity: 15 pg/ml
Calibrator: Human FGF23 Mature Form (25-251)
Sample Type: cell culture, serum, EDTA plasma
Sample Required: 100uL of diluted samples per well
Intra-CV: 6-8%
Inter-CV: 10-12%
Protocol: PDF